Comparison between Mann Fleet Partners IPO and Ujin Pharma IPO.
Mann Fleet Partners IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ujin Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Mann Fleet Partners IPO | Ujin Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Khambatta Securities Ltd. | Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. SMC Capitals Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Mann Fleet Partners IPO is up to ₹0.00 Cr whereas the issue size of the Ujin Pharma IPO is up to ₹0.00 Cr. The final issue price of Mann Fleet Partners IPO is and of Ujin Pharma IPO is .
| Mann Fleet Partners IPO | Ujin Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 64,10,000 shares | 1,18,69,100 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 16,00,000 shares | 72,82,300 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 80,10,000 shares | 1,91,51,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Mann Fleet Partners IPO opens on , while Ujin Pharma IPO opens on . The closing date of Mann Fleet Partners IPO and Ujin Pharma IPO is , and , respectively.
Mann Fleet Partners IPO P/E ratio is , as compared to Ujin Pharma IPO P/E ratio of .
| Mann Fleet Partners IPO | Ujin Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.61 | 98.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.93 | 12.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.88 | 12.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.75 | 1.57 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.93 | 11.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mann Fleet Partners IPO Retail Individual Investors (RII) are offered 0 shares while in Ujin Pharma IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Mann Fleet Partners IPO and 0 shares in Ujin Pharma IPO.
| Mann Fleet Partners IPO | Ujin Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Mann Fleet Partners IPO subscribed in total, whereas Ujin Pharma IPO subscribed .
